
Regulatory Policy Committee's opinion of the review of the Human Medicines Regulations 2012 carried out by MHRA.
A second post-implementation review of the Human Medicines Regulations 2012 was led by the Medicines and Healthcare products Regulatory Agency (MHRA), an executive agency of the Department of Health … [+458 chars]









